Abstracts tagged "systemic sclerosis and interstitial lung disease"

Abstract Number: 2608 • 2019 ACR/ARP Annual Meeting
Subsets in Systemic Sclerosis-ILD: Working Towards Consensus-Based Definitions
David Roofeh¹, Kevin Brown ², Donald Tashkin ³, Shervin Assassi ⁴, Shaney Barratt ⁵, Elana Bernstein ⁶, Nitin Bhatt ⁷, Lorinda Chung ⁸, Harold Collard ⁹, Richard Conway ¹⁰, Paul Dellaripa ¹¹, Christopher Denton ¹², Oliver Distler ¹³, Robyn Domsic ¹⁴, Tracy J. Doyle ¹⁵, Puneet Garcha ¹⁶, Nishant Gupta ¹⁷, Anna Maria Hoffmann-Vold ¹⁸, Vivien Hsu ¹⁹, Francesca Ingegnoli ²⁰, Kerri Johannson ²¹, Bashar Kahaleh ²², Leticia Kawano-Dourado ²³, Ella Kazerooni ¹, Surabhi Khanna ¹⁷, Peter Korsten ²⁴, Celia JF Lin ²⁵, Toby Maher ²⁶, Stephen Mathai ²⁷, Fernando Martinez ²⁸, Eric Matteson ²⁹, Vivek Nagaraja ³⁰, Chester Oddis ³¹, Juan Ovalles-Bonilla ³², John Pauling ³³, Ganesh Raghu ³⁴, Ignasi Rodriguez-Pinto ³⁵, Ivan Rosas ¹⁵, James Seibold ³⁶, Virginia Steen ³⁷, Vibeke Strand ³⁸, Elizabeth Volkmann ³⁹, Dharshan Vummidi ³⁰, Simon Walsh ⁴⁰, Donald Zoz ⁴¹, Athol Wells ⁴² and Dinesh Khanna ⁴³, ¹University of Michigan, Ann Arbor, ²National Jewish Health, Denver, ³University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, ⁴Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, Texas, USA, Houston, TX, ⁵North Bristol NHS Trust, Bristol, England, United Kingdom, ⁶Columbia University, New York City, ⁷Ohio State University Wexner Medical Center, Columbus, ⁸Stanford University, Palo Alto, CA, ⁹University of California San Fransisco, San Fransisco, ¹⁰Blackrock Clinic, Dublin, Ireland, ¹¹Brigham and Women's Hospital, Boston, MA, ¹²University College London Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, London, UK, London, United Kingdom, ¹³Dept. of Rheumatology, University Hospital Zürich, Zürich, Switzerland, Zürich, Switzerland, ¹⁴University of Pittsburgh, Pittsburgh, PA, ¹⁵Brigham and Women's Hospital, Harvard Medical School, Boston, ¹⁶Baylor Scott & White Health, Dallas, ¹⁷University of Cincinnati, Cincinnati, ¹⁸Department of Rheumatology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, ¹⁹Rutgers- RWJ Medical School, SOUTH PLAINFIELD, NJ, ²⁰Division of Clinical Rheumatology, ASST Pini-CTO, Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Milan, Italy, Milano, Italy, ²¹University of Calgary, Calgary, ²²University of Toledo, Toledo, OH, ²³University of Sao Paulo, Sao Paulo, Brazil, ²⁴University Medical Center Göttingen, Göttingen, Germany, ²⁵Genentech, San Fransisco, ²⁶National Heart and Lung Institute, Imperial College London, UK and National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK, London, United Kingdom, ²⁷John Hopkins Pulmonary and Critical Care Medicine, Baltimore, ²⁸Will Cornell Medicine Pulmonary & Critical Care Medicine, New York, ²⁹Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA, Rochester, ³⁰University of Michigan, Ann Arbor, MI, ³¹University of Pittsburgh Medical Center, Pittsburgh, PA, ³²Hospital Gregorio Marañón, Madrid, Spain, ³³Department of Rheumatology, Royal National Hospital of Rheumatic Diseases, Royal United Hospitals NHS Foundation Trusts, Bath, England, United Kingdom, ³⁴University of Washington, Seattle, USA, Seattle, ³⁵University of Barcelona, Barcelona, Spain, ³⁶Scleroderma Research Consultants LLC, Aiken, South Carolina, USA, Aiken, ³⁷Georgetown University, Washington, D.C., USA, Georgetown, ³⁸Division of Immunology/Rheumatology, Stanford University, Stanford, CA, ³⁹University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, ⁴⁰Kings College London, London, United Kingdom, ⁴¹Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA, Ridgefield, CT, ⁴²Royal Bromptom Hospital, London, United Kingdom, ⁴³Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA, Ann Arbor
Background/Purpose: Systemic sclerosis associated interstitial lung disease (SSc-ILD) is heterogeneous, with varying degrees of severity and risk of disease progression. No consensus-based definitions of disease…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].